World Cancer Day recognizes the millions of people affected by cancer each and every day. One cancer survivor in Saratoga ...

Lantheus, a Massachusetts-based developer of radiopharmaceuticals, has agreed to acquire the radiopharma contract development and manufacturing organization (CDMO) Evergreen Theragnostics. Lantheus ...

Dr. Jonathan R. Strosberg, discussed results of the CABINET trial evaluating Cabometyx versus placebo in advanced ...

As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer ...

DINNER: Enjoy a delicious meal and great entertainment at Cabell Midland High School’s Collegium musicum’s annual Valentine’s ...

With the aim to add a “revenue generating CDMO arm,” Lantheus Holdings has bought New Jersey-based radiopharmaceutical ...

Rare cancers are less known and pose challenges due to limited research and diagnostic difficulties. Environmental factors, ...

First, know that chatbots – ChatGPT, Claude, Perplexity, Copilot, Gemini, and others – are an immensely powerful type of AI ...

Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, ...

Topline results from the COMPETE trial showed that ITM-11 met the study’s primary end point of PFS in inoperable, progressive ...

Shrinking' star Harrison Ford exclusively told Us Weekly why he hasn't shared the screen with wife Calista Flockhart ...

In a video interview, William K. Oh, MD, director of precision medicine at Yale Cancer Center and Smilow Cancer Hospital discusses the latest breakthroughs in advanced prostate cancer treatment.